4
Changes in Ownership
RESMED INC Filed Acc 0001127602-25-004041
Chief Executive Officer sold 8,009 shares at $236.77 ($1,896,307)
- Chief Executive Officer acquired 8,009 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2025-02-07 | Option exercise 10b5-1 | +8,009 | $101.64 | $814,035 | 463,481 | D: show line 1 in the form |
| Farrell Michael J. Chief Executive Officer | 2025-02-07 | Sale 10b5-1 | −8,009 | $236.77 | $1,896,307 | 455,472 | D: show line 2 in the form |
| Open-market sales · 8,009 sh · avg $236.77 · $1,896,307 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2025-02-07 | Option exercise · ResMed Common Stock Options 10b5-1 | −8,009 | 72,083 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…